CytoSelect™ 96-well Phagocytosis Assay (Zymosan)
Specifications | |
---|---|
Product Category: | Phagocytosis Assays |
Product Description
- Fast and accurate quantification of phagocytosis
- Protocol based on engulfing Zymosan particles
- No manual counting
- High-throughput compatible
Zymosan (Saccharomyces cerevisiae) is prepared from yeast cell wall and consists of protein-carbohydrate complexes. Zymosan is a commonly used pathogen in phagocytosis assays. Typically, engulfed Zymosan particles are manually counted (expressed as a phagocytosis index or engulfed particles per phagocyte). This manual counting method is quite cumbersome, time-consuming, and difficult when testing a large number of samples.
The CytoSelect™ 96-well Phagocytosis Assay (Zymosan particle based) uses prelabeled Zymosan particles as a phagocytosis pathogen; however, it does not involve subjective manual counting of Zymosan particles inside cells. Instead external Zymosan particles are blocked before the colorimetric detection of engulfed particles.
This format provides a quantitative, high-throughput method to accurately measure phagocytosis.
Each kit provides sufficient quantities to perform 96, 48, 24 tests in a 96, 48, 24-well plate, respectively.
Assay Principle
Fig.1. Principle of the CytoSelect™ 96-well Phagocytosis Assay (Zymosan).
Performance Data
Fig.2. Particle engulfment with the CytoSelect™ 96-well Phagocytosis Assay (Zymosan).
Product Citations
- Trivedi, M.K. et al. (2017) Immunomodulatory potential of nanocurcumin-based formulation. Inflammopharmacol.
- Rawat, P. & Spector, S. A. (2016) Development and characterization of a human microglia cell model of HIV-1 infection. J Neurovirol.
- Sapkota, M. et al. (2016) Malondialdehyde-acetaldehyde-adducted surfactant protein alters macrophage functions through Scavenger Receptor A. Alcoholism Clin.
- Beringer, P. M. et al. (2015) Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa. J Antimicrob Chemother.
- Fiorcari, S. et al. (2015) Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia. Haematologica.
- Catalog Number
CBA-224-CB - Supplier
Cell Biolabs - Size
- Shipping
RT